AKTS Aktis Oncology pre-market +8.54% at $21.98 03 Feb 2026: Watch 50-day
Aktis Oncology (AKTS) is trading higher in the pre-market after an oversold bounce lifted the share price 8.54% to $21.98 on 03 Feb 2026. AKTS stock saw 163,423 shares change hands versus an average of 527,480, signaling measured buying interest in the United States market on NASDAQ. Traders are watching the 50-day average $20.87 for confirmation of follow-through. This piece outlines technical triggers, valuation metrics, analyst context and a short-term trade plan for an oversold-bounce setup using Meyka AI’s market analysis platform.
Continue Reading on Meyka
This article is available in full on our main platform. Get access to complete analysis, stock insights, and more.
Read Full Article →